C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 487/04 (2006.01) A61K 31/40 (2006.01) A61P 29/00 (2006.01)
Patent
CA 2602224
The present invention relates to a new crystalline modification of 6- ( 4- chlorophenyl) -2, 2-dimethyl-7- phenyl-2, S-dihydro-lH-pyrrolizin-S-ylacetic acid which is referred to as polymorph B. It has a peak in the solid state 13C- NMR spectrum (with adamantane as external reference standard; CH group d = 29.45 ppm) in the range from 179.8 to 180.2 ppm and can be processed directly to a pharmaceutical formulation.
La présente invention concerne une nouvelle forme cristalline de l'acide 6-(4-chlorophényl)-2,2-diméthyl-7-phényl-2,3-dihydro-1H-pyrrolizin-5-ylacétique désignée sous le nom de forme polymorphe B. Cette forme polymorphe présente un pic dans le spectre de RMN 13C à l'état solide (avec l'adamantane comme norme de référence externe; d du groupement CH = 29,45 ppm) entre 179,8 et 180,2 ppm et peut être directement élaborée sous forme de formule pharmaceutique.
Albrecht Wolfgang
Kammermeier Thomas
Laufer Stefan
Merckle Philipp
Striegel Hans-Guenter
Borden Ladner Gervais Llp
Merckle Gmbh
LandOfFree
Polymorphic form of 6- (4-chlorophenyl) -2,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polymorphic form of 6- (4-chlorophenyl) -2,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polymorphic form of 6- (4-chlorophenyl) -2,... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1369228